Antibodies to von Willebrand factor in von Willebrand disease.

[1]  M. Blombäck,et al.  Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I. , 1992, American journal of human genetics.

[2]  M. Blombäck,et al.  Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III. , 1992, Human molecular genetics.

[3]  D. Mancuso,et al.  Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual. , 1990, Blood.

[4]  J. Batlle,et al.  Further specificity characterization of von Willebrand factor inhibitors developed in two patients with severe von Willebrand disease. , 1988, Blood.

[5]  J. Koziol,et al.  Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Mannucci,et al.  Life‐threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor , 1987, European journal of haematology.

[7]  A. Federici,et al.  Gene deletions correlate with the development of alloantibodies in von Willebrand disease. , 1987, The Journal of clinical investigation.

[8]  P. Mannucci,et al.  Atherosclerosis and von Willebrand factor , 1984, British Journal of Haematology.

[9]  P. Mannucci,et al.  Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases. , 1979, The Journal of laboratory and clinical medicine.

[10]  A. Ordinas,et al.  Inhibition of Willebrand factor in von Willebrand disease. , 1979, Thrombosis research.

[11]  N. Ardaillou,et al.  Heterogeneity of von Willebrand's disease: Study of 40 Iranian Cases , 1977, British journal of haematology.

[12]  M. Blombäck,et al.  On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease. , 1976, Thrombosis research.

[13]  P. Mannucci,et al.  Precipitating antibodies in von Willebrand's disease , 1976, Nature.

[14]  K. Brinkhous,et al.  Antibody nature of circulating inhibitor of plasma von Willebrand factor. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Brinkhous,et al.  Nature of von Willebrand factor: a new assay and a specific inhibitor. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Mannucci,et al.  Alloantibodies in congenital von Willebrand’s disease , 1991, La Ricerca in clinica e in laboratorio.

[17]  P. Mannucci,et al.  Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy. , 1981, Blood.

[18]  R. Furlong,et al.  High potency factor VIII concentrate: more effective than cryoprecipitate in a patient with von Willebrand's disease and inhibitor. , 1979, Thrombosis research.